Search
IDEXX Laboratories Inc
IDXXAdd to Watchlist
562.090USD
+16.000+2.93%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
44.54BMarket Cap
41.07P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of IDEXX Laboratories Inc is 7.75, ranking 120 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 787.50, with a high of 850.00 and a low of 475.21.
Analyst Rating
Based on
16
analysts
Buy
Current Rating
709.358
Target Price
+29.90%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
IDEXX Laboratories Inc
IDXX
16
Medtronic PLC
MDT
33
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is IDEXX Laboratories Inc's expected revenue for the next quarter?
IDEXX Laboratories Inc's expected revenue is 1.20B.
What is IDEXX Laboratories Inc's price target?
Analysts forecast that IDEXX Laboratories Inc's price target is USD 787.50, with the highest forecast at USD 850.00 and the lowest forecast at USD 475.21.
How have IDEXX Laboratories IncIDXX's recent earnings per share performed?
The market expectation was USD 3.50, while IDEXX Laboratories IncIDXX's earnings per share (EPS) for the previous quarter was USD 3.11. EPS for the next quarter is expected at USD 3.95.
What is the analyst rating for IDEXX Laboratories Inc?
Based on the ratings of IDEXX Laboratories Inc's stock from 16 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
